SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
2024-09-03 4:44:19 PM | Chg. -0.380 | Volume | Bid4:56:27 PM | Ask4:56:27 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
34.520EUR | -1.09% | 92 Turnover: 3,203.420 |
34.460Bid Size: 261 | 34.560Ask Size: 261 | 5.2 bill.EUR | 0.43% | 34.16 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 1.01 EUR | - |
EPS Diluted: | - EUR | - |
Revenues per Share: | 5.97 EUR | - |
Book Value per Share: | 4.58 EUR | - |
Cash Flow per Share: | 1.21 EUR | - |
Dividend per Share: | 0.15 EUR | - |
Total | in mill. | |
Revenues: | 898.60 EUR | - |
Net Income: | 151.84 EUR | - |
Operating Cash Flow: | 181.65 EUR | - |
Cash and Cash Equivalents: | 24.35 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 34.16 | 31.33 |
P/S Ratio: | 5.78 | 5.30 |
P/BV ratio: | 7.53 | 6.90 |
P/CF Ratio: | 28.61 | 26.23 |
PEG: | - | - |
Earnings Yield: | 2.93% | 3.19% |
Dividend Yield: | 0.43% | 0.47% |
Market Capitalization | ||
Market Capitalization: | 5.2 bill. EUR | 4.77 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 1.12 mill. EUR | 1.03 mill. EUR |
Shares Outstanding: | 150.62 mill. |
Profitability
Gross Profit Margin: | 35.22% |
EBIT Margin: | 21.41% |
Net Profit Margin: | 16.90% |
Return on Equity: | 21.99% |
Return on Assets: | 12.33% |
Financial Strength
Liquidity I / Cash Ratio: | 6.93% |
Liquidity II / Quick Ratio: | 51.55% |
Liquidity III / Current Ratio: | 133.37% |
Debt / Equity Ratio: | 78.41% |
Dynam. Debt / Equity Ratio: | 298.04% |
Efficiency
Employees: | 4,646 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 193,413.69 EUR |
Net Income / Employee: | 32,681.88 EUR |
Total Assets / Employee: | 265,135.60 EUR |
* Fiscal Year End: | 2023-09-30 |
Accounting Standard: | IFRS |
Currency: | EUR |